A detailed history of Clear Creek Financial Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Clear Creek Financial Management, LLC holds 11,963 shares of BMY stock, worth $685,838. This represents 0.07% of its overall portfolio holdings.

Number of Shares
11,963
Previous 12,355 3.17%
Holding current value
$685,838
Previous $513,000 20.66%
% of portfolio
0.07%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$39.66 - $51.75 $15,546 - $20,286
-392 Reduced 3.17%
11,963 $619,000
Q2 2024

Jul 25, 2024

BUY
$40.25 - $52.99 $252,166 - $331,982
6,265 Added 102.87%
12,355 $513,000
Q1 2024

Apr 26, 2024

BUY
$47.98 - $54.4 $292,198 - $331,296
6,090 New
6,090 $330,000
Q3 2020

Nov 10, 2020

SELL
$57.43 - $63.64 $197,444 - $218,794
-3,438 Closed
0 $0
Q2 2020

Jul 16, 2020

BUY
$54.82 - $64.09 $188,471 - $220,341
3,438 New
3,438 $202,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Clear Creek Financial Management, LLC Portfolio

Follow Clear Creek Financial Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Creek Financial Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Creek Financial Management, LLC with notifications on news.